title: Adaptation of esophageal mucosa to acid- and pepsin-induced damage: role of nitric oxide and epidermal growth factor.
abstract: To study whether the esophageal mucosa was able to elicit mucosal adaptation, we induced esophageal damage by perfusing acidified pepsin in rabbits. Mucosal adaptation was induced by preexposing the esophageal mucosa to a mild irritant (acidified saline) for 60 min prior to acidified pepsin (strong irritant). Macroscopic and microscopic esophageal injury, cell proliferation, and mucosal barrier function (H+, K+, hemoglobin flux rates) were studied. Preexposure of the esophageal mucosa to acidified saline significantly decreased both the mucosal damage and the mucosal barrier dysfunction induced by acidified pepsin. The development of this phenomenon was nondependent on cell proliferation. Concomitant treatment with either the nitric oxide synthase inhibitor, N(G)-nitro-L-arginine, or the perfusion of immunospecific EGF-receptor antibodies or tyrphostin-25, an inhibitor of the tyrosine kinase activities ligated to the intracytoplasmatic domain of the EGF receptor, during the preexposure period completely reversed the protection induced by acid. We conclude that the rabbit esophageal mucosa shows mucosal adaptation to acid and pepsin. The development of this phenomenon is fast, not dependent on cell proliferation, and dependent, at least in part, on nitric oxide and EGF-receptor-mediated mechanisms.
authors.affiliation: Services of Gastroenterology and Pathology, Hospital Clinico, Unidad Mixta de Investigacion, University of Zaragoza, Spain.
authors.forename: A I
authors.initials: AI
authors.lastname: Lanas
authors.forename: J M
authors.initials: JM
authors.lastname: Blas
authors.forename: J
authors.initials: J
authors.lastname: Ortego
authors.forename: J
authors.initials: J
authors.lastname: Soria
authors.forename: R
authors.initials: R
authors.lastname: Sáinz
mesh_terms: D000222:Adaptation, Physiological; D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004815:Epidermal Growth Factor / Q000502:physiology*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000502:physiology*; D004942:Esophagitis, Peptic / Q000139:chemically induced / Q000503:physiopathology*; D004947:Esophagus / Q000503:physiopathology*; D009092:Mucous Membrane / Q000503:physiopathology; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D009570:Nitriles / Q000494:pharmacology; D019335:Nitroarginine / Q000494:pharmacology; D010434:Pepsin A; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011817:Rabbits; D012965:Sodium Chloride; D020032:Tyrphostins
chemical_list: D004791:Enzyme Inhibitors; D009570:Nitriles; D020032:Tyrphostins; C079836:tyrphostin 25; D019335:Nitroarginine; D009569:Nitric Oxide; D012965:Sodium Chloride; D004815:Epidermal Growth Factor; D019001:Nitric Oxide Synthase; D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases; D010434:Pepsin A